Sativa Board

Latest articles

ANNOUNCEMENT: Sativa joins the ACI toxicology study to further it’s commitment to Novel Food compliance

As part of the Sativa Group PLC’s ongoing commitment to continually deliver the highest level of regulatory compliance and substantiate ‘CBD you can trust’, the Company has become a member of the Association for the Cannabinoid Industry (ACI) Novel Food consortium and it’s landmark toxicology study, which will augment the submission of it’s own Novel Food application dossier.

ANNOUNCEMENT: Sativa joins the ACI toxicology study to further it’s commitment to Novel Food compliance

As part of the Sativa Group PLC’s ongoing commitment to continually deliver the highest level of regulatory compliance and substantiate ‘CBD you can trust’, the Company has become a member of the Association for the Cannabinoid Industry (ACI) Novel Food consortium and it’s landmark toxicology study, which will augment the submission of it’s own Novel Food application dossier.

ANNOUNCEMENT: Update Regarding Re-Listing of the Common Shares of Stillcanna Inc. on the Canadian Securities Exchange

Further to the Company’s news release dated September 10, 2020, Sativa wishes to provide an update on the status of the re-listing of Stillcanna Inc. (to be renamed Sativa Wellness Group Inc.) (“Stillcanna”) common shares on the Canadian Securities Exchange (the “CSE”) and the AQSE Growth Market (the “AQSE”). The Company is currently co-ordinating with Stillcanna a date of re-listing with the CSE, and continues to work diligently to fulfil the remaining conditions of re-listing.

ANNOUNCEMENT: Conditional CSE Approval of Sativa Wellness Group Inc

The Company is pleased to announce that the Canadian Securities Exchange (“CSE”) conditionally approved the Listing Application for Sativa Wellness Group Inc. on September 7, combining the operations of Sativa Group PLC and Stillcanna Inc. As previously announced, Sativa shareholders voted 99% in favour of the merger, with Stillcanna shareholders voting 99.9% in favour, and the Court sanctioned the Scheme of Arrangement, subject to unconditional CSE approval. Unconditional approval and the resumption of trading on the CSE of Sativa Wellness Group Inc.

ANNOUNCEMENT: Court Sanction of Scheme of Arrangement and update to timetable Suspension

Further to the announcement issued by the Company on 1 September 2020, the Company is pleased to announce that yesterday the Court sanctioned the Scheme in connection with the recommended offer by Stillcanna for the entire issued share capital of the Company to be satisfied by the issuance of shares in Stillcanna.

Notwithstanding the sanctioning of the Scheme by the Court, it has been ordered that upon receipt (but not before) by the Company from Stillcanna of the unconditional approval given to it by the Canadian Securities Exchange of the Acquisition undertaken pursuant to the Scheme (“CSE Approval”), the Order of the Court be produced to the Registrar of Companies of England and Wales and that an office copy be delivered to the Registrar together with a copy of the CSE Approval. The Scheme will only become effective on the date upon which the Order of the Court and a copy of the CSE Approval is filed with the Registrar of Companies in England and Wales (the “Scheme Effective Date”)…

ANNOUNCEMENT: Grant of MIP Shares

Sativa Group Plc (AQSE: SATI), the UK’s leading quoted CBD wellness and medicinal cannabis company, announces that certain options having reverted back to Geremy Thomas from former employees of the Group, having lapsed due to vesting conditions not having been met…

ANNOUNCEMENT: Notice of Scheme Sanction Hearing

Further to the announcement issued by Sativa Group PLC on 18 August 2020, the Company gives notice that the Scheme Sanction Hearing, at which the Court will consider whether to exercise its discretion to sanction the Scheme, will take place at 10.30 a.m. (London time) on 28 August 2020 before the Honourable Mr Justice Snowdon…

ANNOUNCEMENT: Another Record Month

Further to the announcement made by the Company on 23 June 2020, Sativa Group Plc, the UK’s leading quoted CBD wellness and medicinal cannabis Group, announces that it and StillCanna Inc have agreed to extend the date by which the Scheme Document must be posted to Sativa Shareholders until tomorrow, 22 July 2020.

ANNOUNCEMENT: CBD and Vitamin D Product Launch

Further to the announcement made by the Company on 23 June 2020, Sativa Group Plc, the UK’s leading quoted CBD wellness and medicinal cannabis Group, announces that it and StillCanna Inc have agreed to extend the date by which the Scheme Document must be posted to Sativa Shareholders until tomorrow, 22 July 2020.